CinDome Pharma announces successful completion of thorough QT study of CIN-102 (deudomperidone) in healthy subjects.
CIN-102, Deudomperidone, is a novel, deuterium-containing, peripherally selective dopamine (D2/D3) receptor antagonist. Study demonstrated that…